Today's Top Gainer
Note:Top Gainer - Nifty 50 More
|Chairman||Ashok M Kadakia|
|Managing Director||MSR Ayyangar|
|Director||Manoj M Shah|
|Director||Vijay K Agrawal|
Emmessar Biotech & Nutrition Ltd, originally started on 17th March 1992 as Emmessar Chemical Industries Ltd (ECIL) started with its operations manufacturing Super Specialty Fine Chemicals. In its in-house R&D, the Company succeeded in developing many Specialty Fine Chemicals. ECIL gained official recognition for its R&D from DSIR, Ministry of Science & Technology, Government of India, New-Delhi in early 1996.On realizing that some of the specialty chemicals developed & exported to USA & Europe was being used in producing healthcare formulations, the Company plunged into a new venture in the Healthcare business, where phenomenal growth in the coming decades was anticipated.ECILs research team established that the specialty chemicals made by them had potential as Vital Micro Nutrients, used worldwide in research as tools of Biotechnology. The Companys management took opportunity to also enter the field of Biotechnology & Healthcare, at a time when across the world, healthcare ranked high in priority in both manufacturers and consumers minds.To better represent its new core activity, a change in the companys name from Emmessar Chemical Industries Ltd (ECIL) to Emmessar Biotech & Nutrition Ltd (EBNL) on April 7, 2000, became essential.EBNLs R&D pursued its research and while identifying potential markets for their products in Healthcare, the Company in 1998, entered into collaborative partnership with California based, Vibrant Life, a company well established and reputed in the USA.The intellectual exchange of concepts and technology between Emmessar Biotech & Nutrition Ltd., and Vibrant Life, led to path-breaking discoveries (VedaCeuticals) through a combination of core fundamentals of Nutraceuticals, Cosmeceuticals, Ayurveda, Biotechnology and Nanotechnology - giving a new dimension to future products emerging from the stable.EBNLs range of products covers different aspects and unmet needs of Healthcare. They cater to and address obstinate skin problems, muscle problems, bone problems and other debilitating chronic physical ailments.EBNL is a Public Limited Company, with a paid-up Share Capital of about Rs. 50.00 million (over US$ 1.00 million). The Companys stocks are traded on The Bombay Stock Exchange Ltd.